Ann Richmond

17.4k citations

166 papers · 12.9k indexed · 2 hit papers · h-index 62

Impact in

Immunology top 0.2%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Response and Inflammation
Oncology top 0.2%
- Chemokine receptors and signaling
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology and Allergy 29
- Cell Adhesion Molecules Research 29
Oncology 112
- Chemokine receptors and signaling 57
- Cytokine Signaling Pathways and Interactions 22
- Cancer Immunotherapy and Biomarkers 18
- Cancer Cells and Metastasis 11

Co-authors: Punita Dhawan Jinming Yang Dayanidhi Raman Gwendal Lazennec Anna E. Vilgelm Jiqing Sai Yingjun Su Yee Mon Thu
Journals: Journal of Biological Chemistry (14 papers)Cancer Research (10 papers)Journal of Leukocyte Biology (8 papers)Clinical Cancer Research (5 papers)Biochemistry (5 papers)
Partner nations: United States Australia Switzerland

In The Last Decade

Ann Richmond

162 papers receiving 12.8k citations

Hit Papers

align trajectories log scale

Chemokines and chemokine receptors: new insights into cancer-related inflammation 2010 · 542 citations

Peers

Countries citing papers authored by Ann Richmond

Since Specialization

Citations

This map shows the geographic impact of Ann Richmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Richmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Richmond more than expected).

Fields of papers citing papers by Ann Richmond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Richmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Richmond. The network helps show where Ann Richmond may publish in the future.

Co-authors

The 25 scholars most cited alongside Ann Richmond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ann Richmond Line = papers co-authored together Ann Richmond links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer Cancers ·李从熙, Ann Richmond	2024	7
2	Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma Cancers ·Chi Yan, Caroline A. Nebhan, Nabil Saleh, Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Gregory D. Ayers, Vivian Weiß, Ann Richmond, Anna E. Vilgelm	2023	5
3	Loss of Vascular Endothelial Glutaminase Inhibits Tumor Growth and Metastasis, and Increases Sensitivity to Chemotherapy Cancer Research Communications ·Verra M. Ngwa, Deanna N. Edwards, Yoonha Hwang, ヨアヒムケラー, Alastair Hamilton, Chi Yan, Ann Richmond, Dana M. Brantley‐Sieders, Jin Chen	2022	5
4	Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer International Journal of Molecular Sciences ·Rontani Jean-François, Ann Richmond, Chi Yan	2022	50
5	Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy Cancers ·李从熙, Ann Richmond	2021	46
6	Metabolic modulation by CDK4/6 inhibitor promotes chemokine-mediated recruitment of T cells into mammary tumors Cell Reports ·Roman V. Uzhachenko, Vijaya Bharti, Zhufeng Ouyang, Gerardo Rappazzo Amura, Stacey Mont, Nabil Saleh, Martha Segura, Chengli Shen, Sheau‐Chiann Chen, Gregory D. Ayers, David G. DeNardo, Carlos L. Arteaga, Ann Richmond, Anna E. Vilgelm	2021	61
7	Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy Breast Cancer Research and Treatment ·Carly Bess Scalise, Caroline A. Nebhan, Jinming Yang, Julio Cezar Rubin de Rubin, Chi Yan, Anna E. Vilgelm, Sheau‐Chiann Chen, Gregory D. Ayers, Vandana G. Abramson, Ingrid A. Mayer, Ann Richmond	2020	6
8	A Requirement for p120-catenin in the metastasis of invasive ductal breast cancer Journal of Cell Science ·Sarah J. Kurley, Verena Tischler, Brian Bierie, Sergey V. Novitskiy, Aurelia Noske, Manuel Ordorica-Collado, Ursina Zürrer‐Härdi, Simone Brandt, Robert H. Carnahan, Rebecca S. Cook, William J. Muller, Ann Richmond, Albert B. Reynolds	2020	5
9	Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition Clinical Cancer Research ·Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Emily Murray, Christopher Andrew Johnson, G. Bruzual, Jamye F. O’Neal, Rami N. Al‐Rohil, Caroline A. Nebhan, Vijaya Bharti, Kimberly B. Dahlman, Gregory D. Ayers, Chi Yan, Mark C. Kelley, Rondi M. Kauffmann, Mary Hooks, Ana M. Grau, Douglas B. Johnson, Anna E. Vilgelm, Ann Richmond	2020	22
10	MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21 Science Translational Medicine ·Anna E. Vilgelm, Nabil Saleh, Rebecca L. Shattuck-Brandt, Pascal Hériveau, Thành Chơn Nguyễn, Sheau‐Chiann Chen, Christopher Andrew Johnson, Jinming Yang, Gerardo Rappazzo Amura, Chi Yan, Douglas B. Johnson, Rami N. Al‐Rohil, Ensar Halilovic, Rondi M. Kauffmann, Mark C. Kelley, Gregory D. Ayers, Ann Richmond	2019	88
11	Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms Cancer Immunology Research ·Jinming Yang, Amrendra Kumar, Anna E. Vilgelm, Sheau‐Chiann Chen, Gregory D. Ayers, Sergey V. Novitskiy, Sebastian Joyce, Ann Richmond	2018	57
12	PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses Clinical Cancer Research ·Jiqing Sai, Philip Owens, Sergey V. Novitskiy, Oriana E. Hawkins, Anna E. Vilgelm, Jinming Yang, Tammy Sobolik, Nicole Lavender, Andrew C. Johnson, Colt M. McClain, Gregory D. Ayers, Mark C. Kelley, Melinda E. Sanders, Ingrid A. Mayer, Harold L. Moses, Mark Boothby, Ann Richmond	2016	89
13	Combining an Aurora Kinase Inhibitor and a Death Receptor Ligand/Agonist Antibody Triggers Apoptosis in Melanoma Cells and Prevents Tumor Growth in Preclinical Mouse Models Clinical Cancer Research ·Yan Liu, Oriana E. Hawkins, Anna E. Vilgelm, Jeff S. Pawlikowski, Jeffrey Ecsedy, Jeffrey A. Sosman, Mark C. Kelley, Ann Richmond	2015	20
14	Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells Cancer Research ·Anna E. Vilgelm, Jeff S. Pawlikowski, Yan Liu, Oriana E. Hawkins, Tyler A. Davis, 法子桑島, Kevin P. Weller, Linda W. Horton, Colt M. McClain, Gregory D. Ayers, David C. Turner, 佳伟管, Clinton F. Stewart, Jeffrey A. Sosman, Mark C. Kelley, Jeffrey Ecsedy, Jeffrey N. Johnston, Ann Richmond	2014	82
15	Myeloid IKKβ Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response Cancer Research ·Jinming Yang, Oriana E. Hawkins, Whitney Barham, Pavlo Gilchuk, Mark Boothby, Gregory D. Ayers, Sebastian Joyce, Michael Karin, Fiona E. Yull, Ann Richmond	2014	36
16	Ikk4a/Arf Inactivation with Activation of the NF-κB/IL-6 Pathway Is Sufficient to Drive the Development and Growth of Angiosarcoma Cancer Research ·Jinming Yang, Sara Kantrow, Jiqing Sai, Oriana E. Hawkins, Mark Boothby, Gregory D. Ayers, Eric D. Young, Elizabeth G. Demicco, Alexander J. Lazar, Dina Lev, Ann Richmond	2012	30
17	RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors Clinical Cancer Research ·Yingjun Su, Anna E. Vilgelm, Mark C. Kelley, Oriana E. Hawkins, Yan Liu, Kelli L. Boyd, Sara Kantrow, Ryan Splittgerber, Sarah P. Short, Tammy Sobolik, Snjezana Zaja‐Milatovic, Kimberly B. Dahlman, Katayoun I. Amiri, Aixiang Jiang, Lu Wang, Yu Shyr, Darrin D. Stuart, Shawn Levy, Jeffrey A. Sosman, Ann Richmond	2012	47
18	Systemic Targeting Inhibitor of κB Kinase Inhibits Melanoma Tumor Growth Cancer Research ·Jinming Yang, رضوان الطريبق, Gary A. Clawson, Ann Richmond	2007	43
19	Deletion of the COOH-Terminal Domain of CXC Chemokine Receptor 4 Leads to the Down-regulation of Cell-to-Cell Contact, Enhanced Motility and Proliferation in Breast Carcinoma Cells Cancer Research ·Yukiko Ueda, Nicole F. Neel, Evemie Schutyser, Dayanidhi Raman, Ann Richmond	2006	46
20	CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer The Journal of Experimental Medicine ·Dingzhi Wang, Haibin Wang, Joanne R. Brown, Takiko Daikoku, Ning Wei, Qiong Shi, Ann Richmond, Robert M. Strieter, Sudhansu K. Dey, Raymond N. DuBois	2006	287

About Ann Richmond

Ann Richmond is a scholar working on Immunology and Allergy, Oncology, Immunology, Cancer Research and Cell Biology, having authored 166 papers that have together received 12.9k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (57 papers), Cell Adhesion Molecules Research (29 papers), Immunotherapy and Immune Responses (28 papers), NF-κB Signaling Pathways (23 papers), Cytokine Signaling Pathways and Interactions (22 papers), Cancer Immunotherapy and Biomarkers (18 papers), Melanoma and MAPK Pathways (16 papers) and Cancer Cells and Metastasis (11 papers). The work is most often cited by research in Immunology (5.4k citations), Oncology (6.3k citations), Immunology and Allergy (1.0k citations), Cancer Research (1.9k citations) and Molecular Biology (5.1k citations). Ann Richmond has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Punita Dhawan, Jinming Yang, Dayanidhi Raman, Gwendal Lazennec, Anna E. Vilgelm, Jiqing Sai, Yingjun Su, Yee Mon Thu, Katayoun I. Amiri and Paige J. Baugher. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Journal of Leukocyte Biology, Clinical Cancer Research and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact